Imatinib Mesylate in Patients With Various Types of Malignancies Involving Activated Tyrosine Kinase Enzymes
Conditions
- Hypereosinophilic Syndrome
- Systemic Mastocytosis
- Chronic Myelomonocytic Leukemia
- Dermatofibrosarcoma
Interventions
Sponsor
Novartis Pharmaceuticals